Spin-out targets better cancer treatment
Wednesday, January 25, 2012 - 12:02
in Health & Medicine
A new Oxford University spin-out firm, Oxford Cancer Biomarkers Limited, is to develop technology to ensure that only patients who are likely to benefit from anti-cancer drugs will receive them and that the best treatment for each person can be quickly identified.